In mid- year 2019, profit of pharmaceuticals lost steam as cash-strapped Nigerians’ self-medication on cheap smuggled drugs and preference for alternative medicine, among others, significantly worsened the already floundering growth of listed drug makers.
Listed players pared profit by 29 percent
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
